Cvs Health (CVS) Payables (2009 - 2026)

Cvs Health (CVS) has reported Payables for 18 consecutive years, with $17.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables fell 15.43% year-over-year to $17.2 billion; the trailing twelve-month figure through Jun 2026 stood at $17.2 billion (down 15.43% YoY), and the FY2025 full-year result was $17.6 billion, down 2.05% from the prior year.
• Payables improved to $17.2 billion in Q2 2026 per CVS's latest filing, from $16.9 billion in the prior quarter.
• Across five years, Payables topped out at $20.3 billion in Q2 2025 and bottomed at $12.5 billion in Q1 2023.
• Historically, Payables has averaged $15.9 billion across 5 years, with a median of $15.8 billion in 2023.
• The sharpest annual moves came in 2025 and 2026: Payables soared 40.8% in 2025, then decreased 15.43% in 2026.
• Over 5 years, Payables stood at $14.8 billion in 2022, then grew by 1.75% to $15.1 billion in 2023, then gained by 19.3% to $18.0 billion in 2024, then fell by 2.05% to $17.6 billion in 2025, then slipped by 2.69% to $17.2 billion in 2026.
• According to Business Quant data, Payables over the past three periods registered $17.2 billion, $16.9 billion, and $17.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.